KR101343283B1 - 수 현탁성을 향상시킨 세립제 - Google Patents

수 현탁성을 향상시킨 세립제 Download PDF

Info

Publication number
KR101343283B1
KR101343283B1 KR1020107024757A KR20107024757A KR101343283B1 KR 101343283 B1 KR101343283 B1 KR 101343283B1 KR 1020107024757 A KR1020107024757 A KR 1020107024757A KR 20107024757 A KR20107024757 A KR 20107024757A KR 101343283 B1 KR101343283 B1 KR 101343283B1
Authority
KR
South Korea
Prior art keywords
weight
fine
surfactant
silicon dioxide
polyoxyethylene
Prior art date
Application number
KR1020107024757A
Other languages
English (en)
Korean (ko)
Other versions
KR20110003357A (ko
Inventor
가즈아키 요시오카
마코토 노아미
료지 도모시게
Original Assignee
시오노기 앤드 컴파니, 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시오노기 앤드 컴파니, 리미티드 filed Critical 시오노기 앤드 컴파니, 리미티드
Publication of KR20110003357A publication Critical patent/KR20110003357A/ko
Application granted granted Critical
Publication of KR101343283B1 publication Critical patent/KR101343283B1/ko

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020107024757A 2008-04-04 2009-04-03 수 현탁성을 향상시킨 세립제 KR101343283B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008098204A JP2011153075A (ja) 2008-04-04 2008-04-04 水懸濁性を向上させた細粒剤
JPJP-P-2008-098204 2008-04-04

Publications (2)

Publication Number Publication Date
KR20110003357A KR20110003357A (ko) 2011-01-11
KR101343283B1 true KR101343283B1 (ko) 2013-12-18

Family

ID=41135667

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107024757A KR101343283B1 (ko) 2008-04-04 2009-04-03 수 현탁성을 향상시킨 세립제

Country Status (6)

Country Link
JP (1) JP2011153075A (fr)
KR (1) KR101343283B1 (fr)
CN (1) CN102056610B (fr)
RU (1) RU2488396C2 (fr)
TW (1) TWI426913B (fr)
WO (1) WO2009123304A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101756906B (zh) * 2009-11-02 2011-11-16 严洁 盐酸头孢卡品酯颗粒的药物组合物及其制备方法
JP6192919B2 (ja) 2012-11-02 2017-09-06 Ntn株式会社 インホイールモータ駆動装置
JP6196730B2 (ja) * 2014-03-31 2017-09-13 富山化学工業株式会社 セファロスポリンエステルを含む粒状固形製剤およびその製造方法
CN113423570B (zh) * 2019-02-22 2024-05-14 大金工业株式会社 层压体
CN110974803B (zh) * 2019-12-31 2022-03-11 山东罗欣药业集团股份有限公司 一种盐酸头孢卡品酯颗粒剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039538A1 (fr) 2003-10-29 2005-05-06 Shionogi & Co., Ltd. Procede de production de preparation enrobee dont le gout desagreable est attenue

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242568A (ja) * 1994-03-04 1995-09-19 Eisai Co Ltd 苦味隠蔽製剤
US20040022848A1 (en) * 2000-09-19 2004-02-05 Hiroshi Kikuchi Medicinal composition
JP4945108B2 (ja) * 2004-09-24 2012-06-06 興和株式会社 イソソルビド製剤
JP2007211006A (ja) * 2006-01-16 2007-08-23 Ono Pharmaceut Co Ltd 溶出安定性を有するコーティング固形製剤
JP2007197375A (ja) * 2006-01-27 2007-08-09 Pfizer Japan Inc アジスロマイシン類を有効成分とする帯電防止作用を有する組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039538A1 (fr) 2003-10-29 2005-05-06 Shionogi & Co., Ltd. Procede de production de preparation enrobee dont le gout desagreable est attenue

Also Published As

Publication number Publication date
CN102056610A (zh) 2011-05-11
WO2009123304A1 (fr) 2009-10-08
JP2011153075A (ja) 2011-08-11
CN102056610B (zh) 2013-07-17
KR20110003357A (ko) 2011-01-11
RU2488396C2 (ru) 2013-07-27
RU2010145148A (ru) 2012-05-20
TWI426913B (zh) 2014-02-21
TW201004625A (en) 2010-02-01

Similar Documents

Publication Publication Date Title
EP1771161B1 (fr) Formulation de masquage du gout comprenant un medicament a dissolution retardee et/ou de la cyclodextrine a dissolution amelioree
EP2180882B2 (fr) Préparation pharmaceutique à matrice solide
KR101252863B1 (ko) 안정성이 향상된 고형 제제 및 그 제조 방법
JP5202856B2 (ja) トシル酸トスフロキサシンを含有する粒状固形製剤
WO2007074856A1 (fr) Procede de production de preparation solide se desintegrant dans la cavite orale
PL194802B1 (pl) Kompozycja farmaceutyczna o wysokiej dostępności biologicznej zawierająca fenofibrat oraz sposób wytwarzania kompozycji farmaceutycznej o wysokiej dostępnosci biologicznej zawierającej fenofibrat
EP3862318A1 (fr) Composition de particules de silice poreuse
KR101343283B1 (ko) 수 현탁성을 향상시킨 세립제
JP5197015B2 (ja) 抗生物質用即効型投薬形
JPH0717866A (ja) 医薬組成物
MXPA06001481A (es) Jarabe en seco que contiene loratadina.
JP4853818B2 (ja) イブプロフェン及び塩酸アンブロキソール含有固形製剤
JP2000500477A (ja) 即時放出型の薬学的組成物
JP3221891B2 (ja) 咀嚼可能な製薬錠剤調製のための回転造粒及び味覚遮蔽被覆加工
JP3981134B2 (ja) 不快味を改善した被覆製剤の製造方法
JP4336380B1 (ja) 水懸濁性を向上させた細粒剤
JP2005139086A (ja) 速崩壊製剤
KR102246658B1 (ko) 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
JP2006219462A (ja) 経口製剤用粒子
EP1438960B2 (fr) Composition sous la forme d'une dispersion solide comprenant de l'itraconazole et un polymer hydrophilique dont la biodisponibilité est améliorée
TW201609193A (zh) 含有碳酸鹽之口腔內崩解錠劑用組成物及口腔內崩解錠劑
EP1438961B2 (fr) Composition bioéquivalente sous la forme d'une dispersion solide comprenant de l'itraconazole et un polymer hydrophile
KR100441745B1 (ko) 이트라코나졸의 경구투여용 조성물과 그 제조방법
JP2022074105A (ja) リナグリプチン含有顆粒及び医薬組成物

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161123

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20171114

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20181121

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191120

Year of fee payment: 7